Computed head-to-head · 6 dimensions
ABT vs MDT
Abbott Laboratories versus Medtronic plc — yield, safety, growth trend, cost, scale, and tax treatment.
ABT and MDT are evenly matched (1–1 across six dimensions) — the right pick comes down to which dimension you weight most.
Neither ABT nor MDT wins outright — the two are nearly equivalent across all 6 dimensions, making the choice largely a matter of which account you hold them in and personal preference on yield vs stability. ABT and MDT are evenly matched (1–1 across six dimensions) — the right pick comes down to which dimension you weight most.
On yield alone, MDT generates 3.51% vs 2.39% — a 1.12% difference that translates to $1,120 more per year on a $100,000 investment.
Scorecard at a glance
| Dimension | ABT | MDT | Winner |
|---|---|---|---|
| Yield | 2.39% | 3.51% | MDT wins |
| Dividend safety | 6.8/10 | 6.8/10 | Tie |
| Growth trend | +0.57% vs 5y | +0.48% vs 5y | Tie |
| Volatility (beta) | 0.59 | 0.58 | Tie |
| Scale | $183.3B | $106.5B | ABT wins |
| Tax efficiency | Qualified-eligible | Qualified-eligible | Tie |
| Overall | 1 wins | 1 wins | Tie |
Dimension by dimension
MDT wins on yield (3.51% vs 2.39%)
On a $10,000 investment that's about $112 more in annual dividend income before taxes — though higher yield often comes with higher risk.
MDT's higher yield (3.51%) looks attractive but investors should weigh whether the extra income compensates for any additional risk versus ABT's 2.39% — especially if the higher yield is driven by covered calls or a falling share price.
Safety scores are too close to call (6.8/10 vs 6.8/10)
Both score within 0.3 points on our 0-10 dividend safety scale — comparable risk profiles on the signals we measure.
Yield trends are similar
Both tickers' current yields sit close to their 5-year averages, suggesting comparable dividend-vs-price trajectories.
Volatility (beta) is similar
Both tickers move with comparable sensitivity to the broader market.
ABT is 1.7× larger by market cap
Larger companies tend to have tighter spreads, deeper liquidity, and lower closure risk.
Both pay qualified-dividend-eligible distributions
Neither is structurally flagged for ordinary-income tax treatment. Most distributions should qualify for the lower long-term capital gains rate if holding-period requirements are met.
How we compare these
Every comparison on this page is computed from current public data, not written by hand. Yield comes from the most recent dividend distribution annualized over current price. Safety scores combine yield zone, payout ratio, trend vs 5-year average, instrument type, and size — see our methodology for the exact formula. Tax-efficiency flags identify covered-call ETFs, REITs, and mREITs which distribute primarily as ordinary income.
This is educational, not investment advice.Scores reflect a snapshot of public data on the "as of" dates shown on each ticker's safety page. Verify on the issuer's investor relations page or your brokerage before making decisions.
Frequently asked
Which is better for income, ABT or MDT?
ABT and MDT are evenly matched (1–1 across six dimensions) — the right pick comes down to which dimension you weight most.
ABT vs MDT: which has a higher dividend yield?
ABT yields 2.39% and MDT yields 3.51%. On a $10,000 investment that's about $112 more in annual dividend income before taxes — though higher yield often comes with higher risk.
Is ABT or MDT a safer dividend in 2026?
ABT scores 6.8/10 (Solid) on the Infnits dividend safety scale. MDT scores 6.8/10 (Solid). Both have comparable safety scores.
Which has better dividend growth, ABT or MDT?
Both tickers' current yields sit close to their 5-year averages, suggesting comparable dividend-vs-price trajectories.
ABT vs MDT: which is more tax-efficient?
Neither is structurally flagged for ordinary-income tax treatment. Most distributions should qualify for the lower long-term capital gains rate if holding-period requirements are met.
Get emailed when ABT vs MDT data updates.
Already own ABT or MDT? See if the other adds anything.
Connect your brokerage and Infnits checks whether adding either to your existing portfolio actually diversifies — or just duplicates exposure (ETF look-through included).
Check overlap with my portfolio →